
Marijuana and testicular cancer (Sidebar)
More details from recent research by Drs. Janet Daling and Stephen Schwartz
February 9, 2009
By Kristen Woodward
For the study on marijuana use and testicular-cancer risk, Drs. Janet Daling and Stephen Schwartz and
colleagues interviewed 369 Seattle-Puget Sound-area men, ages 18 to 44,
who had been diagnosed with testicular cancer about their history of
marijuana use. For comparison purposes they also assessed marijuana use
among 979 randomly selected age- and geography-matched healthy
controls. (More than 90 percent of the cases and 80 percent of the
controls in the study were Hispanic or non-Hispanic white men, due to
the fact that testicular cancer is very rare in African Americans, and
because the Seattle-Puget Sound region has a relatively small African
American population.)
Study participants were also asked about
other habits that may be correlated with marijuana use, including
smoking and alcohol consumption. Even after statistically controlling
for these lifestyle factors, as well as other risk factors, such as
first-degree family history of testicular cancer and a history of
undescended testes, marijuana use emerged as a significant, independent
risk factor for testicular cancer.
“Our study is the first inkling that marijuana use may be associated
with testicular cancer, and we still have a lot of unanswered
questions,” Schwartz said, such as why marijuana appears to be
associated with only one type of testicular cancer.
“We need
to conduct additional research to see whether the association can be
observed in other populations, and whether measurement of molecular
markers connected to the pathways through which marijuana could
influence testicular cancer development helps clarify any association
that exists,” he said.
In the meantime, Schwartz
said, “What young men should know is that first, we know very little
about the long-term health consequences of marijuana smoking,
especially heavy marijuana smoking; and second, our study provides some
evidence that testicular cancer could be one adverse consequence,” he
said. “So, in the absence of more certain information, a decision to
smoke marijuana recreationally means that one is taking a chance on
one’s future health."
In future studies, the researchers plan to measure the expression of cannabinoid receptors in both seminomatous and nonseminomatous tumor tissue from the cases in the study, and to see whether variation in the genes for the receptors and other molecules involved in cannabinoid signaling influences the risk of testicular cancer.
According to the National Cancer Institute, testicular cancer is very rare, accounting for only 1 percent of cancers in U.S. men. About 8,000 men are diagnosed with testicular cancer each year, and about 390 die of the disease annually. It is the most common form of cancer in men between the ages of 15 and 34 and is most common in white men, especially those of Scandinavian descent.
Sidebar: Marijuana use and testicular cancer
February 9, 2009
Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024 Seattle, WA 98109
©2009 Fred Hutchinson Cancer Research Center, a nonprofit organization.
Terms of Use & Privacy Policy.
